Siflon Pharma Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 28-10-2024
- Paid Up Capital ₹ 34.17 Cr
as on 28-10-2024
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 74.09 Cr
as on 28-10-2024
About Siflon Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 34.17 Cr.
The company currently has active open charges totaling ₹74.09 Cr.
The Key Managerial Personnel (KMP) at Siflon Pharma Private Limited India is Jatanghi Shilpa as COMPANY SECRETARY. Ananthaiah Rallapalli, Parvathi Rallapalli, and Swetha Rallapalli serve as directors at the Company.
- CIN/LLPIN
U24200AP2022PTC121807
- Company No.
121807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Ananthapur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Siflon Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ananthaiah Rallapalli  | Managing Director | 27-May-2022 | Current |
| Jatanghi Shilpa | Company Secretary | 02-Sep-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parvathi Rallapalli | Director | 27-May-2022 | Current |
| Swetha Rallapalli | Director | 27-May-2022 | Current |
Financial Performance of Siflon Pharma.
Siflon Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Siflon Pharma?
In 2023, Siflon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Siflon Polymers Private LimitedActive 21 years 8 monthsAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Drugs And Pharmaceuticals Private LimitedActive 18 years 10 monthsAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Drugs Private LimitedActive 14 years 9 monthsAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Drip And Sprinklers Private LimitedActive 8 years 10 monthsAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Manoj Animal Health Private LimitedActive 5 years 2 monthsAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
- Siflon Engineering Private LimitedActive 10 years 1 month
Ananthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Mar 2024 | ₹9.75 Cr | Open |
Axis Bank Limited Creation Date: 08 Dec 2023 | ₹64.34 Cr | Open |
How Many Employees Work at Siflon Pharma?
Siflon Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siflon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
